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Abstract
Introduction: Chemokines and their receptors are potential therapeutic targets in rheumatoid arthritis (RA). Among
these, several studies suggested the involvement of CXC chemokine 4 (CXCR4) and its ligand CXC ligand 12 (SDF-
1) in RA pathogenesis. However, the role of these molecules in T-cell function is not known completely because of
embryonic lethality of Cxcr4- and Cxcl12-deficient mice. In this report, we generated T cell-specific Cxcr4-deficient
mice and showed that the CXCR4 in T cells is important for the development of collagen-induced arthritis (CIA).
Methods: T cell-specific Cxcr4-deficient mice were generated by using the Cre-loxP system. Mice harboring loxP
sites flanking exon 2 of the Cxcr4gene (Cxcr4
flox/flox) were generated by homologous recombination and crossed
with Cre transgenic mice expressing Cre recombinase under the control of Lck promoter (Cxcr4
+/+/Lck-Cremice) to
generate T cell-specific Cxcr4-deficient mice (Cxcr4
flox/flox/Lck-Cre mice). CIA was induced by immunization with
chicken type II collagen and Complete Freund’s Adjuvant (CFA).
Results: The incidence, but not the severity, of CIA was significantly reduced in Cxcr4
flox/flox/Lck-Cre mice compared
with Cxcr4
+/+/Lck-Cre mice. We found that the expression of CXCR4 was enhanced in activated T cells, and the
migration of Cxcr4-deficient T cells toward SDF-1 was severely impaired. However, antibody production, cellular
proliferative response, and cytokine production on treatment with type II collagen (IIC) were normal in these
knockout mice, suggesting that CXCR4 is not involved in T-helper functions. Interestingly, the proportion of CXCR4-
expressing T cells was much increased in affected joints compared with that in draining lymph nodes in CIA-
induced mice, and distribution of Cxcr4
flox/flox/Lck-Cre mouse-derived T cells into affected joints was suppressed
compared with that in Cxcr4
+/+/Lck-Cre T cells.
Conclusions: These results indicate that CXCR4 expression in T cells is important for the development of CIA, by
recruiting activated T cells toward inflammatory sites, and suggest that CXCR4 is a good target for the treatment of
RA in humans.
Introduction
Rheumatoid arthritis (RA) is an autoimmune disease
affecting about 1% of the world population and charac-
terized by chronic inflammation of multiple joints, pro-
liferation of the synovial cells, and destruction of the
cartilage and bone of the affected joints. Genetic factors
and environmental agents are assumed to be involved in
the development of disease, but the precise etiopatho-
genesis has not been elucidated completely [1,2].
To elucidate the complex RA pathogenesis, various
disease models of RA have been developed [1,3]. Col-
lagen-induced arthritis (CIA), one of the well-established
animal models of RA, can be induced in mice by immu-
nization with type II collagen (IIC) [4,5]. Although the
concept that humoral and cellular immunity to IIC is
crucial for the development of CIA is widely accepted,
multiple chemokines and cytokines are also important
for the pathogenesis.
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receptor expressed in various cells of the immune sys-
tem and the central nervous system [6-8]. CXCR4 med-
iates migration of resting hematopoietic progenitors and
B cells in response to its ligand, CXC ligand 12 (SDF-1),
which is involved in various phenomena such as hema-
topoiesis and the development or survival of B cells
[7,9]. Furthermore, the SDF-1-CXCR4 system is also
suggested to be involved in the T-cell receptor (TCR)
signaling [10] or cell migration or both [6].
Accumulating evidence suggests the involvement of
the SDF-1-CXCR4 system in the pathogenesis of RA.
CXCR4-expressing CD4
+CD45RO
+ T cells are abun-
dantly detected in the synovial tissues of RA patients
[11]. T helper (Th) 1 cells, which are believed to be
involved in the pathogenesis in part, are attracted by RA
synovial fluid, and chemotaxis is interfered by anti-SDF-
1a n t i b o d yin vitro [12]. SDF-1 is expressed at high
levels in RA synovial tissues [13]. Furthermore, it is sug-
gested that CXCR4 is important for T-cell retention in
RA synovial tissues [11]. However, the importance of
T cell-expressing CXCR4 in the development of RA and
the functional role of CXCR4 in T cells still remain
obscure, because many other cells, such as B cells and
osteoclasts, also express CXCR4. Because null-knockout
mice of Cxcr4 and Cxcl12 genes are embryonic lethal
[14-16], it was difficult to elucidate the roles of this
molecule in different cell types in the pathogenesis of
diseases.
In this study, we generated T cell-specific Cxcr4-
deficient mice and showed that the incidence of CIA
was significantly decreased in these mice. Moreover,
we confirmed that T cells migrate toward SDF-1 in a
CXCR4-dependent manner in vitro, and CXCR4-expres-
sing T cells were enriched in the affected joints during
the development of CIA, suggesting involvement of T
cell-expressing CXCR4 in the development of RA.
Materials and methods
Mice
Cxcr4
flox/flox mice were generated as described pre-
viously in detail [17]. In brief, 4.7 kb of mouse genomic
fragment containing the second exon of the Cxcr4 gene
was floxed by two loxP sites containing neomycin-resis-
tant (Neo
r) gene, and the diphtheria toxin A (DT-A)
gene was inserted to the upstream of the 5’ arm for
negative selection (Figure 1a). Targeted E14.1 ES cells
were aggregated with C57BL/6J embryos, and the chi-
meric mice were crossed with C57BL/6J mice to obtain
a germline-transmitted mouse. After intercrossing this
mouse with proximal Lck promoter (Lck)-Cre transgenic
mice (C57BL/6J background, kindly provided by Dr.
Junji Takeda, Osaka University) [18], Cxcr4
flox/+/Lck-Cre
mice were backcrossed to the DBA/1J mice (Charles
River Laboratories) for eight generations. Then they
were intercrossed to obtain Cxcr4
flox/flox/Lck-Cre,
Cxcr4
+/+/Lck-Cre,a n dCxcr4
flox/flox mice on the DBA/1J
background. Unless otherwise indicated, Cxcr4
+/+/Lck-
Cre mice on the DBA/1J background were used as con-
trols. Age- and gender-matched mice were used for all
experiments. Mice were housed under specific patho-
gen-free conditions in an environmentally controlled
clean room at the Center for Experimental Medicine
and Systems Biology, Institute of Medical Science, Uni-
versity of Tokyo. Experiments were performed according
to the ethical guidelines for animal experimentation,
which was approved by the Institutional Animal Care
and Use Committee (reference number A17-5) and the
safety guidelines for gene manipulation.
Collagen-induced arthritis
CIA was induced as described previously [19]. In brief,
mice were immunized with 100 μlo f2m g / m lc h i c k e n
IIC (Sigma-Aldrich, St. Louis, MO) emulsified in Com-
plete Freund’s Adjuvant (CFA; Difco) intradermally at
three sites near the base of the tail on day 0. On day 21,
the mice were given booster injection with the same
amount of IIC/CFA intradermally near the former injec-
tion sites.
Clinical and histologic assessment of arthritis
Development of arthritis by macroscopic evaluation was
determined as described previously [19]. For histologic
assessment of arthritis, limbs were fixed with 10% neu-
tral formalin and were decalcified with 5% formic acid
60 days after the first immunization, and embedded in
paraffin. Then 5-μm slices were prepared. Sections were
stained with hematoxylin-eosin (H&E).
Analysis on IIC-specific T-cell response
IIC-specific T-cell proliferative response was performed
as previously described [20]. In brief, inguinal and infra-
axillary lymph nodes (LNs) were harvested from mice 7
days after the primary immunization with chicken IIC
with CFA. A single-cell suspension was prepared, and 3
×1 0
5 cells/well in 96-well flat-bottom plates (Falcon)
were cultured in the absence or presence of 50, 100, or
200 μg/ml of heat-denatured chicken IIC at 37°C for 72
hours, followed by incorporation of 25 μCi/ml [
3H]-thy-
midine (Amersham, Chalfont St. Giles, Buckingham-
shire, UK) for 6 hours. Then, cells were harvested with
a Micro 96 cell harvester (Skatron, Lier, Norway), and
radioactivity was measured with Micro Beta (Pharmacia
Biotech, Piscataway, NJ). The concentrations of IL-17A
and IFN-g in the culture supernatant were determined
by commercially available ELISA kits (Ready-Set-Go!
M o u s eI L - 1 7 AE L I S Af r o me B i o s c i e n c ea n dM o u s e
IFN-g ELISA kit from R&D systems).
Chung et al. Arthritis Research & Therapy 2010, 12:R188
http://arthritis-research.com/content/12/5/R188
Page 2 of 140
20
40
60
80
100
20 30 40 50 60
D
Cxcr4+/+/Lck-Cre
Cxcr4flox/flox/Lck-Cre
Cxcr4flox/flox 
WT
Wild type allele
Floxed allele
10.1 kb
8.3 kb
6.1 kb
+Lck-Cre
exon2
exon2
exon2
DT-A
loxP
5' probe 3' probe
loxP
loxP loxP
Targeting vector
loxP
Deleted allele
NEOr
2.2 kb
S
c
a
I
S
a
c
I
S
a
c
I
X
b
a
I
C
l
a
I
K
p
n
I
S
a
c
I
X
b
a
I
S
c
a
I
X
b
a
I
X
b
a
I
/
S
c
a
I
X
b
a
I
S
c
a
I
Cxcr4flox/flox/Lck-Cre,
developed
*
**
C
A
r
t
h
r
i
t
i
c
 
S
c
o
r
e
/
A
f
f
e
c
t
e
d
 
m
i
c
e
*
**
** *
0
2
20 30 40 50 60
4
6
8
10
12
14
Cxcr4flox/flox/Lck-Cre,
not developed
Cxcr4+/+/Lck-Cre,
developed
B
I
n
c
i
d
e
n
c
e
 
(
%
)
A
NEOr
Figure 1 The development of CIA is suppressed in Cxcr4
flox/flox/Lck-Cre mice. (a) Targeting strategy for the generation of conditional
knockout mice of Cxcr4. T cell-specific Cxcr4-targeted (Cxcr4
flox/flox/Lck-Cre) mice were generated as described in Materials and methods. (b)
Incidence of CIA. (c) Severity of CIA. Mice were immunized with chicken IIC emulsified with CFA intradermally at triple sites into the back on day
0 and 21. Open circles, Cxcr4
+/+ mice (n = 6); open diamonds, Cxcr4
flox/flox mice (n = 6); open triangles, Cxcr4
+/+/Lck-Cre mice (n = 9); solid circles,
Cxcr4
flox/flox/Lck-Cre mice (n = 11). Representative data obtained from two independent experiments are shown. Averages and SDs are indicated
in c. **p < 0.01; Cxcr4
flox/flox/Lck-Cre mice versus Cxcr4
+/+ and Cxcr4
flox/flox mice. *p < 0.05; Cxcr4
flox/flox/Lck-Cre mice versus Cxcr4
+/+/Lck-Cre mice, by
c
2-test. (d) Histologic changes of the joints after induction of CIA. After the inspection of the arthritis development shown in b and c, hindlimbs
were removed at 60 days after the first immunization, and paraffin sections of joints were stained with hematoxylin and eosin. The histology of
the joint of a IIC-immunized and arthritis-developed Cxcr4
+/+/Lck-Cre mouse (Cxcr4
+/+/Lck-Cre, developed) shows severe erosion of the bone
(arrows) and hyperplasia of synovial membrane (*), whereas no such abnormalities are seen in the joints of Cxcr4
flox/flox/Lck-Cre mice that did not
develop arthritis (Cxcr4
flox/flox/Lck-Cre, not developed). A Cxcr4
flox/flox/Lck-Cre mouse that developed arthritis (Cxcr4
flox/flox/Lck-Cre, developed) shows
severe bone erosion (arrows) and pannus-like structure (*), comparable to those of control mice. × 40. Typical histologies are shown in 22
representative sections from three mice for each group.
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Ig titers in serum were determined, as previously
described [20]. In brief, 60 days after the first immuniza-
tions with IIC/CFA, serum was collected. Falcon 3912
Micro Test III Flexible Assay Plates (BD Biosciences, San
Diego, CA) were coated with 0.1 ml/well of 10 μg/ml IIC
in PBS at 4°C overnight. After washing with PBS, serially
diluted serum samples were applied and incubated at
room temperature for 1 hour. Then the wells were
washed with PBS-0.05% Tween20, followed by the addi-
tion of alkaline phosphatase-conjugated goat anti-mouse
IgG and IgM (Zymed, San Francisco, CA). Alkaline phos-
phatase activity was measured with Substrate Phospha-
tase SIGMA104 (Sigma-Aldrich) as the substrate. Results
are expressed by the absorbance at 415 nm.
In vitro chemotaxis assay
Migration of T cells was analyzed as described elsewhere
[21]. In brief, T cells were purified from single-cell sus-
pension of LNs by removing B cells with microbead-con-
jugated anti-mouse B220 antibody (Miltenyi Biotec) and
an Auto-MACS (Miltenyi Biotec). T cells were suspended
in RPMI 1640 with 1% FCS, and 3 × 10
6 cells were
applied onto micropore filters (3.2 μm diameter, 3-μm
pore polycarbonate transwell culture insert; ChemoTx,
Gaithersburg, NeuroProbe). In the lower chamber, SDF-
1a was supplemented in a concentration of 100 ng/ml
a n dc u l t u r e df o r2 . 5h o u r si na5 %C O 2 incubator at
37°C. Then migrated cells in the lower chamber were
counted with a flow cytometer (FACS Calibur; Becton
Dickinson, San Jose, CA) for 30 seconds with medium
flow speeds. All points were determined in triplicate.
In vivo migration assay
T-cell migration in vivo was analyzed by the transfer of
radioisotope-labeled T cells as follows. Recipient mice
were immunized twice with IIC 3 weeks and 1 week
before the T-cell transfer. As the donors, Cxcr4
+/+/Lck-
Cre mice and Cxcr4
flox/flox/Lck-Cre mice were immunized
only once, 1 week before transplantation. Then LNs and
spleens were harvested from the donor mice, and T cells
were purified by using anti-Thy1.2 microbeads (Miltenyi
Biotech) and Auto-MACS. T cells from each genotype
were labeled with either
51Cr (PerkinElmer Life & Analy-
tical Sciences) or
111In-oxin (Nihon Medi+physics) as
previously described [22,23,23,24]. In brief, T cells were
cultured with the indicated radioisotope at room tem-
perature for 15 minutes, and then at 37°C for 15 minutes,
and 1 hour in fresh medium. To compensate for potential
radioisotope-specific artifacts, each cell population was
split into two parts, and one half was labeled with
51Cr,
and the other half with
111In, and we carried out the
same experiments by using different combination of
radioisotopes. Cell suspensions containing equal numbers
of radioisotope-labeled Cxcr4
+/+/Lck-Cre Tc e l l sa n d
Cxcr4
flox/flox/Lck-Cre T cells were prepared, and 0.2 ml of
2×1 0
7 cells/ml cell suspensions was injected to the reci-
pient mice. Twenty hours after injection, LNs and digital
joints were harvested, and the radioactivities were mea-
sured by using a g-counter (Wallac, Turku, Finland).
Radioactivities of
51Cr and
111In were measured sepa-
rately, and cell accumulation was estimated by the radioi-
sotope counts. Cell migration was not affected by the
radioisotopes used for the labeling.
Flow cytometry
Single-cell suspensions were prepared from LNs, spleens,
thymus glands, and joints, and stained with FITC-,
PE-, PerCP-, APC-, or biotin-conjugated antibodies.
Biotinylated antibodies were visualized with PE- or APC-
conjugated streptavidin (BD Biosciences). To prepare sin-
gle-cell suspensions from joints, joints were collected and
digested with 200 units/ml of collagenase (type VIII,
Sigma) and hyaluronidase (1.5 ng/ml) in FCS-supplemen-
ted RPMI1640 medium for 1.5 hour at 37°C with gentle
mixing. Then cells were filtered with cell strainers
(Falcon) and stained. Stained cells were analyzed with
FACSCalibur and FlowJo software. Antibodies to CXCR4
(BD Pharmingen), CD44 (eBioscience), CCR6 (R&D Sys-
tems), CD62L (BD Pharmingen), CD4 (BD Pharmingen),
and CD8 (BD Pharmingen) were used.
Immunohistochemistry
For immunohistochemical analysis, hindlimbs from nor-
mal mice and CIA-affected mice were embedded in
CMC gel with hexane, and cryostat sections (5 μm)
were generated. The sections were fixed in cold acetone
for 5 minutes and blocked with 2% bovine serum albu-
min (Sigma) in PBS with 0.05% Tween 20. Antibodies
used were as follows; biotinylated rat anti-murine
CXCR4 (BD Pharmingen), rabbit anti-murine CD3
(Abcam, Ab16044), biotinylated donkey anti-rat IgG
(Jackson) to amplify the signal from CXCR4, streptavi-
din FITC (BD Pharmingen), and Cy3 goat anti-rabbit
IgG (Jackson). Nuclei were stained with Hoechst 33258
(WAKO). The slides were visualized on a Nikon A1Rsi-
TiE confocal microscope operated by NIS-Elements soft-
ware (see also Additional file 1).
Statistics
Student’s t-test and the c
2-test were used for the statisti-
cal evaluation.
Results
T cell-specific Cxcr4-deficient mice were generated by
crossing Lck-Cre transgenic mice with Cxcr4
flox/flox mice
To investigate the roles of CXCR4 in T cells, we gener-
ated T cell-specific conditional gene-targeted mice, as
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Page 4 of 14described in Materials and methods. Mice harboring lox
P sites flanking the second exon of Cxcr4 gene
(Cxcr4
flox/flox mice) were generated by homologous
recombination (Figure 1a) and crossed with a Lck-Cre
transgenic mouse [18]. Deletion of the Cxcr4 gene and
CXCR4 protein in the thymus of Cxcr4
flox/flox/Lck-Cre
mice was confirmed (Additional file 2a, b). KO mice
were born in the mendelian ratio, and no gross phenoty-
pic abnormalities were observed. Cre recombinase was
activated from the DN3 stage of thymic T-cell develop-
ment in Cxcr4
flox/flox/Lck-Cre mice (Additional file 2c).
No significant abnormalities in T-cell number and
population in LNs and spleen were found in Cxcr4
flox/
flox/Lck-Cre mice, although thymocytes were significantly
reduced (Additional file 2d), indicating that CXCR4 defi-
ciency does not affect peripheral T-cell development.
The development of CIA is significantly impaired in
Cxcr4
flox/flox/Lck-Cre mice
We examined the effect of T cell-specific Cxcr4 defi-
ciency in the development of CIA. The incidence of the
CIA was significantly more decreased in Cxcr4
flox/flox/
Lck-Cre mice than in Cxcr4
+/+ mice, Cxcr4
flox/flox mice,
or Cxcr4
+/+/Lck-Cre mice (Figure 1b). Conversely, no
significant difference was found in the severity score
of the arthritic mice between Cxcr4
flox/flox/Lck-Cre mice
and Cxcr4
+/+/Lck-Cre mice (Figure 1c). In the histologic
analysis, affected joints of both control mice and
Cxcr4
flox/flox/Lck-Cremice showed typical features of
arthritis, characterized by marked perivascular infiltration
of inflammatory cells, synovial hyperplasia, and bone
erosion (Figure 1d). In the joints of nonarthritic
Cxcr4
flox/flox/Lck-Cre mice, these arthritic pathologies
were not detected. These observations suggest that
CXCR4 in T cells plays an important role in the develop-
ment of arthritis.
Thymocytes and LN T cells migrate toward SDF-1 in a
CXCR4-dependent manner
To elucidate functional roles of CXCR4 in T cells, we
examined T-cell chemotaxis to SDF-1 by using chemotaxis
chambers. Thymocytes from Cxcr4
+/+/Lck-Cre mice effi-
ciently migrated to SDF-1 (Figure 2a). In contrast, migra-
tion of Cxcr4
flox/flox/Lck-Cre mouse-derived thymocytes
was greatly reduced. Likewise, T cells purified from LNs of
wild-type mice efficiently migrated toward SDF-1, whereas
cells from Cxcr4
flox/flox/Lck-Cre mice migrated less
efficiently (Figure 2b), indicating that SDF-1-CXCR4-
dependent chemotaxis is functional in T cells, similarly to
hematopoietic cells and mature B cells [25,26].
Humoral and cellular responses to IIC are normal in
Cxcr4
flox/flox/Lck-Cre mice
As antibody production and cellular response to IIC are
important for the development of CIA [5], we next ana-
lyzed the antibody titer in sera and the proliferative
response of LN cells to IIC. Although IIC-specific IgG
in the serum of Cxcr4
flox/flox/Lck-Cre mice tended to
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Figure 2 Cxcr4
flox/flox/Lck-Cremouse-derived T cells show impaired chemotaxis toward SDF-1. The chemotaxis toward SDF-1 of T cells from
Cxcr4
+/+/Lck-Cre mice or Cxcr4
flox/flox/Lck-Cre were assessed with in vitro chemotaxis assays, as described in Materials and methods. Representative
results in at least two independent experiments are shown. (a) Chemotaxis of thymocytes to SDF-1 or medium was compared between Cxcr4
+/+/Lck-Cre mice and Cxcr4
flox/flox/Lck-Cre mice. *P < 0.05, by Student’s t-test. (b) Chemotaxis of purified T cells from LNs was assessed. Results are
shown as mean ± SD of triplicate determinations and are representative of at least two similar experiments. *P < 0.05, by Student’s t-test Open
columns indicate numbers of cells migrated into the chambers filled with medium only, and black columns, into the chambers with the
medium supplemented with SDF-1 (100 ng/ml).
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Page 5 of 14decrease at day 60 of immunization, no significant dif-
ferences between the control mice were found at days 7
and 60 (Figure 3a and Additional file 3a). In addition,
no significant difference of LN cells was found in the
proliferative response to anti-IgM antibodies (Additional
file 3b). These data indicate that B-cell function is nor-
mal in Cxcr4
flox/flox/Lck-Cre mice. To examine the cellu-
lar response to IIC, Cxcr4
flox/flox/Lck-Cre mice and Cxcr4
+/+/Lck-Cre mice were immunized with IIC with CFA,
and LN cells from these mice were restimulated with
IIC in vitro. The proliferative response to IIC was nor-
mal in Cxcr4
flox/flox/Lck-Cre mouse-derived LN cells
(Figure 3b), and levels of IL-17 and IFN-g in the culture
supernatant were also normal (left columns in Figure 3c
and 3d). To confirm these results, we stimulated LN
cells from immunized mice with anti-CD3 antibody
instead of IIC in the same experimental settings and
detected normal levels of IL-17 and IFN-g in the culture
supernatant (right columns in Figure 3c and 3d) in
Cxcr4
flox/flox/Lck-Cre mouse-derived LN cells. In addi-
tion, the expression levels of CD62L, a naïve T-cell mar-
ker, and CD25, a T cell-activation marker, and CCR6
for Th17 marker, were similar between Cxcr4
flox/flox/Lck-
Cre mice and Cxcr4
+/+/Lck-Cre m i c e( F i g u r e3 ea n d
Additional file 4). As it was reported that pretreatment
of T cells with SDF-1 enhances TCR-induced prolifera-
tive response [27,28], we examined the effect of SDF-1
treatment on the IIC-induced T-cell proliferation. How-
ever, no significant enhancement in T-cell proliferative
response was observed in our experimental conditions
(Additional file 5).
CXCR4-expressing T cells are increased in the draining
LNs of arthritic mice
Because CXCR4 was not involved in the humoral and
cellular responses to IIC, we hypothesized that the
CXCR4-mediated chemotaxis of T cells is involved in
the development of CIA. To verify this possibility, we
investigated the proportion of the CXCR4-expressing T
cells in the LNs and the joints (Figure 4a-c, Figure 5,
and Figure 6a-c). DBA/1J mice were immunized with
IIC/CFA to induce arthritis, and the expression of
CXCR4 was determined with FACS analysis. In cells
from the draining LNs, a peak-shift of the intensity was
observed in arthritic mice compared with nonarthritic
mice, indicating that CXCR4 was induced in arthritic
mice (Figure 4a, b, and Additional file 6). Furthermore,
cryostat sections of LNs stained with anti-CD3 and anti-
CXCR4 antibodies revealed that the number of CXCR4-
expressing T cells was increased in the arthritic mice
compared with nonarthritic mice (Figure 4c, summar-
ized in Figure 6c).
The expression of CXCR4 also tended to increase in
nonarthritic mice after IIC/CFA immunization, although
the increase was not statistically significant (Figure 4a,
b). The expression of CXCR4 increased in mice immu-
nized with CFA only, but LN cells from these mice did
not respond to stimulation by IIC or develop arthritis
(Additional file 7). The expression of CXCR4 was signif-
icantly increased in CD62L
low population, indicating
that CXCR4 expression was induced in activated T cells
(Figure 4d). Furthermore, we examined the effect of
anti-CD3 stimulation of LN cells on the CXCR4 expres-
sion in T cells. As shown in Figure 4e, CD44
high T-cell
population contained a higher proportion of CXCR4
high
cells, and the percentage of CXCR4
high cells in CD44
high
T-cell population was higher in arthritic mice, consistent
with the results in Figure 4d. These observations indi-
cate that immune activation of T cells induces CXCR4
expression.
T-cell accumulation in arthritic joints is dependent on
CXCR4 expression in T cells
Next, we examined expression of CXCR4 in arthritic
joints. Although CD3
+ T cells were found in both non-
arthritic and arthritic joints, the number of T cells was
significantly increased in arthritic joints, and most of the
T cells expressed CXCR4 (Figures 5 and 6a). The
expression of the Cxcl12 was also augmented in arthritic
joints (Figure 6b). Furthermore, we found that the
CXCR4
+ cell population in total T cells was much
higher in the inflammatory sites of affected joints than
in LNs (Figure 6c), indicating that CXCR4
+ cells accu-
mulated in the inflammatory sites. It is remarkable that
some CD3
+ T cells were closely apposed to SDF-1-posi-
tive cells in arthritic joints (Additional file 8), consistent
with the idea that SDF-1 attracted these CXCR4-expres-
sing cells.
To show whether T-cell accumulation in the joints
during the development of CIA depends on the CXCR4/
SDF-1 system, T cells from Cxcr4
flox/flox/Lck-Cre mice
and Cxcr4
+/+/Lck-Cre mice were labeled with radioiso-
topes and injected into IIC/CFA-immunized mice, and
T-cell migration into joints was analyzed (Figure 6d).
Recovery of radioisotope-labeled T cells in affected
joints was significantly decreased by the deficiency of
CXCR4. These data clearly indicate that activated T
cells were accumulated in inflamed joints in a CXCR4-
dependent manner.
Discussion
CIA is a model for autoimmune arthritis characterized
by autoantibody production and massive infiltration of
effector cells to joints [29,30]. However, immunization
with native murine IIC shows a much lower incidence
of arthritis in DBA/1J mice [31], and immunization with
heterologous IIC, such as chicken or bovine, shows a
much higher incidence in CIA. A peptide from chicken
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Page 6 of 14Figure 3 Humoral and cellular immune responses against IIC are normal in Cxcr4
flox/flox/Lck-Cre mice. (a) IIC-specific IgG and IgM levels in
the serum were determined with ELISA 60 days after immunization with IIC/CFA. Each circle represents an individual mouse, and averages and
SDs are shown. Cxcr4
+/+/Lck-Cre mice: open columns (n = 9); Cxcr4
flox/flox/Lck-Cre mice: closed columns (n = 11); Cxcr4
flox/flox mice: light gray
columns (n = 6); and WT DBA/1J mice: dark gray columns (n = 6). Data are representative of two independent experiments. (b) T-cell recall
proliferative response toward IIC was assessed 1 week after immunization with IIC/CFA. LN cells from Cxcr4
+/+/Lck-Cre or Cxcr4
flox/flox/Lck-Cre mice
were harvested and cultured in the presence or absence of 50, and 100, 200 μg/ml of denatured IIC at 37°C for 72 hours, and T-cell proliferation
was assessed with [
3H]-thymidine incorporation by using three wells for each mouse. The average and SD of four mice are shown for each
column. Representative data from three independent experiments are shown. IL-17 (c) and IFN-g (d) levels in the culture supernatants were
measured with ELISA. Triplicate (proliferation, IFN-g) or duplicate (IL-17) wells were used for each mouse, and averages and SDs of three mice are
shown. Data are representative of at least two independent experiments. In the right columns, IL-17 (c) and IFN-g (d) levels in cultures of LN cells
from two immunized mice after stimulation with 1 μg/ml of anti-CD3 antibody at 37°C for 72 hours are shown. Averages and SDs of triplicate
wells are shown, and data are representative of two independent experiments. (e) LN cells from immunized mice were pooled and stimulated
with or without 100 μg/ml of IIC for 72 hours. The proportion of CD25
+, CD62L
-, and CCR6
+ cells in CD4
+ cells was analyzed with FACS. Data
from three independent experiments were combined, and averages and SDs are shown.
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Figure 4 CXCR4-expressing T cells are increased in LNs during the development of CIA. DBA/1J mice were immunized with IIC and CFA,
or CFA only, on day 0 and day 21. At day 30, arthritis development was determined, and LN cells were collected. (a) CXCR4 expression was
analyzed with flow cytometry in CD4
+ T cells from IIC and CFA-immunized mice (arthritic and nonarthritic), CFA-immunized mice (nonarthritic),
and normal nonimmunized DBA/1J mice. Representative data from two similar experiments are presented. (b) Proportion of CXCR4
+ cells in CD4
+ cells from normal DBA/1J mice without immunization (n = 3), IIC and CFA-immunized nonarthritic (n = 4) and arthritic (n = 7) and CFA-
immunized nonarthritic (n = 7) mice are shown. Data from two similar experiments were combined. *P < 0.05 by Student’s t test. (c) The
expression of CXCR4 was analyzed with immunohistochemistry. CXCR4 was labeled with green fluorescence, and CD3 was labeled with red
fluorescence. An increased number of CXCR4-expressing T cells is found in LNs from arthritic mice than those from normal mice. Representative
figures among three sections from normal mice and three sections from arthritic mice are presented. White bar represents 20 μm. (d) CXCR4
and CD62L coexpression was analyzed in CD4
+ cells. Representative plots gated on CD4
+ cells are presented, and all the data from 10 normal
nonimmunized mice and 11 IIC/CFA-immunized arthritic mice are summarized on the right. Averages and SDs are shown. *P < 0.05 by Student’s
t test. (e) LN cells from two nonimmunized normal or IIC/CFA-immunized arthritic mice were pooled and cultured in the absence or presence of
1 μg/ml of anti-CD3 antibody for 72 hours, and CXCR4 and CD44 expression was analyzed in CD4
+ cells. Representative plots gated on CD4
+
cells from two independent experiments are shown.
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Page 8 of 14Figure 5 CXCR4 is expressed in most of synovial T cells from arthritic mice. Mice were induced CIA and CXCR4 expression in the affected
joints was analyzed by immunohistochemistry. Cryostat sections of the limb joints from arthritic mice or normal mice were generated and
stained with anti-CD3 and anti-CXCR4 antibodies. (a) Representative data among sections from three normal mice and three arthritic mice are
shown. Data are summarized in Figure 6c. (b) CXCR4 expression on T cells was analyzed with FACS. As described in Materials and methods,
affected limbs from CIA-developed mice were treated with hyaluronidase and collagenase to obtain single-cell suspensions, and stained with
anti-CD4 and anti-CXCR4 antibodies. Representative data among three similar experiments are shown.
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Page 9 of 14IIC (aa. 256 to 270) is known as a major immunodomi-
nant epitope [31,32], and the difference between hetero-
logous IIC and murine IIC, which is important in the
development of arthritis, is the presence of a glutamic
acid at position 266 in chicken IIC. The T-cell response
to this epitope is suggested to break tolerance to induce
responses toward homologous epitopes in murine IIC.
Bovine IIC (256-270)-specific T cells also crossreact
with mouse IIC [32]. Interestingly, human IIC also
shares this immunodominant epitope, because chicken
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Figure 6 T-cell accumulation in arthritic joints is dependent on CXCR4 expression in T cells. (a) CXCR4 was expressed on CD3
+ T cells in
arthritic joints. Cryostat sections from limbs of normal mice or arthritic mice were analyzed with immunohistochemistry. Red, CD3; green, CXCR4;
and blue, nucleus. CD3
+CXCR4
- cells are indicated with white arrows, and CD3
+CXCR4
+ cells with yellow ones. White bars indicate 10 μm.
Representative data from sections of three normal and three arthritic mice are shown. (b) The expression level of SDF-1 in joints was analyzed
with real-time PCR. Normal, joints from nontreated DBA/1J mice (n = 10); arthritic, affected joints from CIA-induced mice (n = 12). Averages and
SDs are shown. (c) CXCR4 expression in CD3
+ cells was summarized from the immunohistochemical analyses of three normal and three arthritic
mice (shown in Figures 4c, 5a, and 6a), and the averages and SDs are presented. Sections of the thymus from a DBA/1J mouse and a Cxcr4
flox/
flox/Lck-Cre mouse were analyzed as the controls (indicated as Thymus WT or Cxcr4
flox/flox/Lck-Cre). (d) In vivo migration of T cells into
inflammatory sites during development of CIA was dependent on CXCR4 expression. T cells from IIC/CFA-immunized Cxcr4
+/+/Lck-Cre mice (n =
4) and Cxcr4
flox/flox/Lck-Cre mice (n = 4) were purified and differentially labeled with
111In and
51Cr, as described in Materials and methods. Cell
suspension containing equal numbers of cells from each genotype was injected into CIA-induced recipient mice. After 20 hours, the
radioactivities in limbs or LNs were measured with a gamma counter. From the percentages of radioactivities distributed in LNs or joints, the
ratio of Cxcr4
flox/flox/Lck-Cre mouse-derived T cells versus Cxcr4
+/+/Lck-Cre mouse-derived T cells was calculated. Data from two similar experiments
were combined, and averages and SDs of five recipient mice are presented.
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Page 10 of 14IIC-reactive T-cell hybridoma responds to human IIC
[33]. Furthermore, anti-human IIC antibodies purified
from RA patients’ sera react with chick and bovine IIC
[34]. Thus, it is believed that chicken IIC-induced CIA
is a good model for human RA.
It was reported that the proportion of CXCR4-expres-
sing memory T cells and the expression of the ligand,
SDF-1, are increased in RA synovium, suggesting that
the SDF-1-CXCR4 system is involved in the pathogen-
esis of RA [11,12,35]. However, the precise functional
roles of this molecule in T cells remains to be eluci-
dated. In this study, we showed that the incidence, but
not the severity, of CIA was significantly decreased in
Cxcr4
flox/flox/Lck-Cre mice, indicating that CXCR4
expression in T cells is important for the development
of CIA. CXCR4 expression was enhanced in activated/
memory T cells, and CXCR4-deficient T cells were
defective in SDF-1-induced chemotaxis. Both CXCR4
expression in T cells and SDF-1 expression in the
affected joints was augmented during the development
of CIA, and CXCR4-expressing T cells were accumu-
lated in the inflammatory sites where SDF-1 was
strongly expressed. Importantly, on induction of CIA,
the proportion of CXCR4-expressing T cells was
increased in the inflammatory sites compared with that
in the draining LNs, and infiltrated T cells were closely
apposed with SDF-1-expressing cells. Although immuni-
zation with CFA without IIC enhanced CXCR4 expres-
sion in T cells, this could not induce arthritis,
suggesting that CXCR4 expression in IIC-specific T cells
is important for the induction of arthritis. Thus, the
SDF-1-CXCR4 system in T cells is important to recruit
memory T cells to the site of inflammation, rather than
to the LNs. Because cytokines such as IL-15 and TGF-b
can induce and/or sustain the expression of CXCR4 in
T cells [12,36], cytokines from activated LN cells in IIC-
immunized mice may enhance CXCR4 expression. Con-
sistent with this notion, we showed that the antibody
production and T-cell response against IIC were normal
in Cxcr4
flox/flox/Lck-Cre mice.
We suggest that CXCR4 expression in T cells plays an
important role in mediating T-cell recruitment to
inflamed sites. However, the importance of T cells, espe-
cially the recruitment of T cells to inflamed sites in the
development of CIA, has been ignored for a long time.
This is because adoptive transfer experiments suggest
the importance of antibodies, but not T cells, in the
development of arthritis [29,31]. CIA can be transferred
by serum from arthritic mice, whereas T-cell transfer
from arthritic mice to normal or lymphopenic mice can-
not induce the development of arthritis [29,31]. How-
ever, it was reported that transfer of splenocytes from
arthritic mice to SCID mice can induce arthritis [37]. In
this experiment, the incidence of arthritis was greatly
decreased when either T cells or B cells were depleted
from the splenocytes. These observations suggest that T
cells are involved in the development of arthritis,
although T cells alone cannot induce arthritis. Further-
more, the involvement of T cells is reported in a col-
lagen-antibody-induced arthritis (CAIA) model, in
which arthritis is induced by the administration of
collagen-specific antibodi e s[ 3 8 ] .T h i sm o d e lh a sb e e n
considered to be independent of T cells, because T cell-
deficient mice were susceptible to CAIA [39]. However,
injection of collagen-specific T cells to CAIA-induced
mice prolonged the disease [39], and T-cell suppression
by CTLA-4 Ig treatment [40] or CTLA-4 Ig and cyclos-
porine treatment [41] in a later phase of CAIA sup-
pressed the severity of arthritis, indicating that T cells
play a role in CAIA as an amplifier. Accordingly, the
following pathogenic processes are suggested. On pro-
duction or administration of antibodies specific to IIC,
these antibodies may activate mast cells by forming
complexes with complements on cartilage IIC in joints,
leading to the secretion of inflammatory cytokines and
chemokines, including IL-1, similar to that reported
in K/BxN arthritic mice [42]. These inflammatory med-
iators may activate synovial cells to recruit effector
T cells, which can secrete various inflammatory media-
tors on activation with endogenous IIC, resulting in the
amplification of inflammation. Our results indicate that
CXCR4-SDF-1 interaction plays an important role in
recruiting effector T cells into inflamed sites.
Although it was reported that CXCR4 signaling
enhances T-cell activation and proliferation in a syner-
gistic manner with TCR signaling [10,27,28,43], the pro-
liferative response of LN cells from IIC-immunized
Cxcr4
flox/flox/Lck-Cre mice was normal on stimulation
with IIC, and the cytokine production from these cells
was also normal. We also did not detect any effects of
SDF-1 on the proliferative response of IIC-immunized T
cells to IIC stimulation. This apparent discrepancy
might be caused by the difference of the experimental
conditions; anti-CD3 antibodies were used to stimulate
T cells in the previous reports [10,27,28,43], whereas
whole LN cells, including antigen-presenting cells, were
activated with natural antigens in our experiments.
W e a kc o s t i m u l a t o r ya c t i v i t yo fC X C R 4m a yb em a s k e d
by the strong costimulatory signaling from the antigen-
presenting cells.
Recently, it was reported that CXCR4 is involved in
the b-selection during thymic T-cell development in
T cell-specific Cxcr4-deficient mice [44]. In contrast to
this report, no significant abnormality was detected in
the T-cell population and cell number in lymph nodes
and the spleen between Cxcr4
flox/flox/Lck-Cre mice and
Cxcr4
+/+/Lck-Cre mice (Additional file 2d and 2e),
although in the thymus, the T-cell number was
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Page 11 of 14decreased without affecting the CD4
+ or CD8
+ cell con-
tent in Cxcr4
flox/flox/Lck-Cre mice. We think this differ-
ence from the previous report was caused by the
difference of the Lck-Cre transgenic mouse line we used.
We found that, in our Cxcr4
flox/flox/Lck-Cre mouse thy-
mus, CXCR4 expression still remained in the DN3 stage
(Additional file 2c), suggesting that this remain-
ing CXCR4 rescued potential defects in the thymic
b-selection.
Cxcr4-deficient mice developed arthritis with very low
incidence (two of 11), but the severity of arthritis was
comparable to that of control mice (Figure 1b-d). These
data suggest that CXCR4 is required for the initiation of
inflammation by recruiting IIC-specific T cells into inflam-
matory sites. However, IIC-specific effector T cells would
migrate into joints by the action of other chemokines or
even by chance, without involvement of CXCR4, although
the frequency may be low. Then these T cells are activated
with IIC in the joints and produce various cytokines and
chemokines, which recruit or activate other inflammatory
cells, such as neutrophils. Therefore, once inflammation
starts, other chemokines and cytokines may play more
important roles than CXCR4, or other chemokines may
substitute for the role of CXCR4 in the later stages of
inflammation, resulting in the development of arthritis in
Cxcr4
flox/flox/Lck-Cre mice. In support for this contention,
we showed that most of the inflammatory cells infiltrated
in inflammatory sites were neutrophils, and only a part of
them were CD3
+ T cells (Figure 5). Furthermore, we
showed that CCR6, which is important for the develop-
ment of arthritis in SKG mice by enhancing the migration
of Th17 cells, was expressed normally in Cxcr4-deficient T
cells (Figure 3e). The expression of CD62L, which is
important for T-cell migration to peripheral tissues, was
also normal (Figure 3e).
On induction of CIA, the expression of SDF-1 was
augmented. Regarding SDF-1, it was reported that
inflammatory cytokines, such as IL-17 [45] and IL-18
[46], can induce production of this molecule by fibro-
blast-like synoviocytes and stromal cells in the RA syno-
vium. Conversely, CXCR4 is induced by TGF-b and IL-
15 [36]. Thus, the cytokine production associated with
the immune response against IIC may activate the
expression of these molecules, resulting in trapping of
activated T cells and recruitment of new T cells to the
inflammatory sites. Because SDF-1-CXCR4 system is
also active in B cells to activate and to migrate [47], in
osteoclasts to produce MMP-9 [48], in chondrocytes to
produce MMP-3 [49], in endothelium to induce angio-
genesis [50], and in Th1 cells to migrate into synovial
tissues [35], this system may play very important roles
in a multiple ways in the development of RA. Therefore,
these findings highlight the SDF-1-CXCR4 system as a
good target for the treatment of RA.
Conclusions
We showed that CXCR4 expressed in T cells plays an
important role in the development of CIA by recruiting
activated/memory T cells into the inflammatory sites.
Additional material
Additional file 1: Supplemental Methods. Materials and methods that
were used in supplemental figures are described in Additional file 1.
Additional file 2: Generation of T cell-specific CXCR4-deficient mice.
(a) Cxcr4 gene in the thymus. Cxcr4
flox/flox/Lck-Cre, Cxcr4
flox/flox, and wild-
type DBA/1J mice was analyzed by Southern blot analysis, as described
in Supplemental Methods in Additional File 1. In brief, genomic DNA
from thymocytes was digested with ScaI/XbaI, and hybridized with 0.8 kb
ScaI fragment as a 5’ probe at 42°C for overnight. Deleted allele, 6.1 kb
(Cxcr4
flox/flox/Lck-Cre); knockin allele, 8.3 kb (Cxcr4
flox/flox); and wild-type
allele, 10.1 kb (WT). (b) CXCR4 expression in thymocytes was assessed
with FACS. (c) Thymocytes were stained with antibodies against CD4,
CD8, CD25, CD44, and CXCR4, and DN3 (CD25
+CD44
- CD4
-CD8
-), DN4
(CD25
-CD44
- CD4
-CD8
-), DP (CD4
+CD8
+), and DN (CD4
-CD8
-) cells were
gated. CXCR4 expression was detected in DN3 and DN4 stages, although
the intensity was somewhat decreased, and only a little CXCR4
expression was detected at the DP stage. Representative data from five
Cxcr4
+/+/Lck-Cre mice and five Cxcr4
flox/flox/Lck-Cre mice are shown. (d) T-
cell numbers (left column) and populations (right column) in the thymus,
LNs, and spleen were determined with flow cytometry. Means and SDs
of data from four Cxcr4
+/+/Lck-Cre mice (white bar) and three Cxcr4
flox/flox/
Lck-Cre mice (black bar) are shown. *P < 0.05, with Student’s t test. (e)
The proportion of CD3
+ T cells in LNs in normal mice and IIC-immunized
mice (day 7) were analyzed with flow cytometry. Means and SDs of data
from three Cxcr4
+/+/Lck-Cre mice (white bar) and three Cxcr4
flox/flox/Lck-Cre
mice (black bar), which were immunized 7 days before, are presented.
Data are representative of more than two independent experiments.
Additional file 3: B-cell response is normal in Cxcr4
flox/flox/Lck-Cre
mice. (a) IIC-specific IgG antibody titer in sera was measured 7 days after
IIC immunization with ELISA. Each circle represents one mouse. (b)
Proliferative response of B cells was measured after stimulation with IgM.
LN cells from IIC-immunized mice (four Cxcr4
+/+/Lck-Cre mice and four
Cxcr4
flox/flox/Lck-Cre mice) were stimulated with/without 1 μg/ml of anti-
IgM antibody for 3 days, and proliferative response was measured with
[
3H]-thymidine incorporation for 6 hours.
Additional file 4: T cells from draining LNs are normally activated in
Cxcr4
flox/flox/Lck-Cre mice after IIC immunization. LN cells from IIC/
CFA-immunized mice were stimulated with or without 100 μg/ml of IIC
at 37°C for 72 hours, and the expression of CD25, CD62L, and CCR6 on
CD4
+ cells was analyzed with FACS. Representative data from three
independent experiments are shown, and all the data are summarized in
Figure 3e.
Additional file 5: T-cell recall response against IIC is not enhanced
by SDF-1. One week after intradermal immunization with chicken IIC/
CFA, LN cells collected from three DBA/1J mice were cultured in fresh
medium for 3 hours and stimulated with SDF-1 (100 ng/ml) for 2.5 hours.
Then these cells were cultured in the presence or absence of 50 μg/ml
of denatured chicken IIC for 72 hours. Proliferative response was
measured with [
3H]-thymidine incorporation in triplicates, and averages
and SDs of triplicates are shown. Data are representative of two
independent experiments.
Additional file 6: CXCR4 expression is elevated in LN T cells from
arthritic mice. CXCR4 expression in draining LN CD4
+ T cells from CIA-
induced mice was examined with flow cytometry. (a) CXCR4 expression
in CIA-induced arthritic DBA/1J mice (arthritic), or nontreated DBA/1J
(normal) mice. Representative data among five normal mice and nine
arthritic mice are shown. (b) Statistical analysis of CXCR4 expression. Each
circle represents an individual mouse, and averages and SDs are shown.
*P < 0.05, Student’s t test.
Additional file 7: Immunization with CFA without IIC cannot induce
CIA. DBA/1J mice were immunized with IIC and CFA (n = 7), or CFA only
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Page 12 of 14(n = 4). (a) Incidence of CIA. (b) T-cell proliferative response against IIC
stimulation. Draining LN cells were stimulated with IIC for 72 hours, and
the proliferative response was measured with [
3H]-thymidine
incorporation for 6 hours. Representative data from two similar
experiments are shown.
Additional file 8: T cells are closely apposed to SDF-1-expressing
cells in arthritic joints. The expression of SDF-1 and CD3 was assessed
in arthritic joints with immunohistochemistry. Green, SDF-1; red, CD3;
and blue, nuclei. Representative data from two arthritic mice are shown.
Abbreviations
IIC: type II collagen; CIA: collagen-induced arthritis; KO: knockout; LN: lymph
node; RA: rheumatoid arthritis.
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